Mother-to-child transmission of HIV-1: Association with malaria prevention, anaemia and placental malaria

HIV Medicine

Volumn 9, Issue 9, 2008, Pages 757-764

  Naniche, Denise ^a   Lahuerta, M ^a   Bardaji, A ^a,b   Sigauque, B ^b,c   Romagosa, C ^a,b   Berenguera, A ^a,b   Mandomando, I ^a,b,c   David, C ^b,c   Sanz, S ^a   Aponte, J ^a   Ordi, J ^a   Alonso, P ^a,b   Menendez, C ^a,b  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b Ministérioda Saúde   (Mozambique)

^c INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

Author keywords

Anaemia; Intermittent preventive treatment; Mother to child transmission; Placental malaria; Pregnancy

Indexed keywords

FANSIDAR; INSECTICIDE; NEVIRAPINE; PLACEBO; VIRUS RNA;

ADULT; ANEMIA; ARTICLE; BED NET; BLOOD SMEAR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG RESPONSE; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MOZAMBIQUE; MULTIVARIATE ANALYSIS; PARASITE IDENTIFICATION; PATIENT COMPLIANCE; PLACENTA DISORDER; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SINGLE DRUG DOSE; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ANEMIA; ANTI-HIV AGENTS; ANTIMALARIALS; CD4 LYMPHOCYTE COUNT; DRUG COMBINATIONS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; MALARIA, FALCIPARUM; MOZAMBIQUE; NEVIRAPINE; PLACENTA DISEASES; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY COMPLICATIONS, INFECTIOUS; PYRIMETHAMINE; RNA, VIRAL; SULFADOXINE; VIRAL LOAD;

EID: 54049101155     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00626.x     Document Type: Article

References (40)

1. UNAIDS/WHO. AIDS Epidemic Update: December 2007. Geneva, Joint United Nations Program on HIV/AIDS and WHO.
2. ter Kuile FO, Parise ME, Verhoeff FH et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 2004; 71: 41-54.
3. Ned RM, Moore JM, Chaisavaneeyakorn S, Udhayakumar V. Modulation of immune responses during HIV-malaria co-infection in pregnancy. Trends Parasitol 2005; 21: 284-291.
4. Kourtis AP, Lee FK, Abrams EJ, Jamieson DJ, Bulterys M. Mother-to-child transmission of HIV-1: Timing and implications for prevention. Lancet Infect Dis 2006; 6: 726-732.
5. De Cock KM, Fowler MG, Mercier E et al. Prevention of mother-to-child HIV transmission in resource-poor countries: Translating research into policy and practice. JAMA 2000; 283: 1175-1182.
6. Brahmbhatt H, Kigozi G, Wabwire-Mangen F et al. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS 2003; 17: 2539-2541.
7. Ayisi JG, van Eijk AM, Newman RD et al. Maternal malaria and perinatal HIV transmission, Western Kenya. Emerg Infect Dis 2004; 10: 643-652.
8. Mwapasa V, Rogerson SJ, Kwiek JJ et al. Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi. AIDS 2006; 20: 1869-1877.
9. Semba RD, Miotti PG, Chiphangwi JD et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994; 343: 1593-1597.
10. Fawzi W, Msamanga G, Spiegelman D, Hunter DJ. Studies of vitamins and minerals and HIV transmission and disease progression. J Nutr 2005; 135: 938-944.
11. Ayouba A, Nerrienet E, Menu E et al. Mother-to-child transmission of human immunodeficiency virus type 1 in relation to the season in Yaounde, Cameroon. Am J Trop Med Hyg 2003; 69: 447-449.
12. Gallagher M, Malhotra I, Mungai PL et al. The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS 2005; 19: 1849-1855.
13. Kublin JG, Patnaik P, Jere CS et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: A prospective cohort study. Lancet 2005; 365: 233-240.
14. Hoffman IF, Jere CS, Taylor TE et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 1999; 13: 487-494.
15. Kapiga SH, Bang H, Spiegelman D et al. Correlates of plasma HIV-1 RNA viral load among HIV-1-seropositive women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 2002; 30: 316-323.
16. Mwapasa V, Rogerson SJ, Molyneux ME et al. The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. AIDS 2004; 18: 1051-1059.
17. Inion I, Mwanyumba F, Gaillard P et al. Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 2003; 188: 1675-1678.
18. Brahmbhatt H, Sullivan D, Kigozi G et al. Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality. J Acquir Immune Defic Syndr 2008; 47: 472-476.
19. WHO/AFRO. Recommendations on the use of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment during pregnancy (IPT) in areas of moderate to high resistance to SP in the African region. http://www.afro.who.int/malaria/publications/ malaria_in_pregnancy_sulfadoxine.pdf 2005.
20. WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited settings: Towards universal access: Recommendations for a public health approach, Geneva, World Health Organization, 2006. Accessed 27 May 2008: http://www.who.int/hiv/ pub/guidelines/pmtctguides3.pdf
21. INDEPTH-Network. Population and Health in Developing Countries. Ottawa, Canada, International Development Research Centre, 2006: 189-195.
22. Menendez C, Bardaji A, Sigauque B et al. Combination of interventions for malaria prevention in pregnancy. PloS One 2008; 3: E1934.
23. Ordi J, Ismail MR, Ventura PJ et al. Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol 1998; 22: 1006-1011.
24. Alonso PL, Sacarlal J, Aponte JJ et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: Randomised controlled trial. Lancet 2004; 364: 1411-1420.
25. Alonso PL, Smith T, Schellenberg JR et al. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 1994; 344: 1175-1181.
26. Ismail MR, Ordi J, Menendez C et al. Placental pathology in malaria: A histological, immunohistochemical, and quantitative study. Hum Pathol 2000; 31: 85-93.
27. Read JS and Committee on Pediatric AIDS. Diagnosis of HIV-1 infection in children younger than 18 months in the United States. Pediatrics 2007; 120: E1547-e1562.
28. Abacassamo F, Enosse S, Aponte JJ et al. Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria. Trop Med Int Health 2004; 9: 200-208.
29. Macete E, Aide P, Aponte JJ et al. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: A randomized, placebo-controlled trial. J Infect Dis 2006; 194: 276-285.
30. Bulmer JN, Rasheed FN, Francis N, Morrison L, Greenwood BM. Placental malaria. I. Pathological classification. Histopathology 1993; 22: 211-218.
31. Semba RD, Gray GE. Pathogenesis of anemia during human immunodeficiency virus infection. J Invest Med 2001; 49: 225-239.
32. van den Broek NR, Letsky EA. Etiology of anemia in pregnancy in south Malawi. Am J Clin Nutr 2000; 72: 247S-256S.
33. Crawley J. Reducing the burden of anemia in infants and young children in malaria-endemic countries of Africa: From evidence to action. Am J Trop Med Hyg 2004; 71: 25-34.
34. Griffiths E. Iron in biological systems, In: Bullen JJ, Griffiths E. eds. Iron and Infection. Chichester, John Wiley & Sons, 1987: 1-25.
35. Weinberg E. Iron and susceptibility to infectious disease. Science 1974; 184: 952-956.
36. John GC, Nduati RW, Mbori-Ngacha D et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: Association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997; 175: 57-62.
37. Baeten JM, Mostad SB, Hughes MP et al. Selenium deficiency is associated with shedding of HIV-1-infected cells in the female genital tract. J Acquir Immune Defic Syndr 2001; 26: 360-364.
38. Claster S. Biology of anemia, differential diagnosis, and treatment options in human immunodeficiency virus infection. J Infect Dis 2002; 185 (Suppl. 2): S105-S109.
39. Mills EJ, Wu P, Seely D, Guyatt GH. Vitamin supplementation for prevention of mother-to-child transmission of HIV and pre-term delivery: a systematic review of randomized trial including more than 2800 women. AIDS Res Ther 2005; 2: 4.
40. Wiysonge CS, Shey MS, Sterne J, Brocklehurst P, Read JS, Dhansay MA. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection: Cochrane systematic review. Int J Epidemiol 2006; 35: 832-833.